Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Feb;41(2):320–324. doi: 10.1038/bjc.1980.48

The ether lipid tumour marker in human liver with hepatocellular carcinoma.

H J Lin, P C Wu, J C Ho
PMCID: PMC2010194  PMID: 6245673

Full text

PDF
320

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony P. P., Vogel C. L., Barker L. F. Liver cell dysplasia: a premalignant condition. J Clin Pathol. 1973 Mar;26(3):217–223. [PMC free article] [PubMed] [Google Scholar]
  2. Bassendine M. F., Chadwick R. G., Lyssiotis T., Thomas H. C., Sherlock S., Cohen B. J. Primary liver cell cancer in Britain--a viral aetiology? Br Med J. 1979 Jan 20;1(6157):166–166. doi: 10.1136/bmj.1.6157.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown R. C., Blank M. L., Kostyu J. A., Osburn P., Kilgore A., Snyder F. Analysis of tumor-associated alkyldiacylglycerols and other lipids during radiation-induced thymic leukemogenesis. Proc Soc Exp Biol Med. 1975 Jul;149(3):808–813. doi: 10.3181/00379727-149-38904. [DOI] [PubMed] [Google Scholar]
  4. Friedberg S. J., Halpert M. Ehrlich ascites tumor cell surface membranes: an abnormality in ether lipid content. J Lipid Res. 1978 Jan;19(1):57–64. [PubMed] [Google Scholar]
  5. Lin H. J., Ho F. C., Lee C. L. Abnormal distribution of O-alkyl groups in the neutral glycerolipids from human hepatocellular carcinomas. Cancer Res. 1978 Apr;38(4):946–949. [PubMed] [Google Scholar]
  6. Lin H. J., Jie L. K., Lee C. L., Lee D. H. Composition of O-alkyl and O-alk-1-enyl moieties in the glycerolipids of the human adrenal. Lipids. 1977 Jul;12(7):620–625. doi: 10.1007/BF02533392. [DOI] [PubMed] [Google Scholar]
  7. Nayak N. C., Dhar A., Sachdeva R., Mittal A., Seth H. N., Sudarsanam D., Reddy B., Wagholikar U. L., Reddy C. R. Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int J Cancer. 1977 Nov 15;20(5):643–654. doi: 10.1002/ijc.2910200502. [DOI] [PubMed] [Google Scholar]
  8. Peters R. L., Afroudakis A. P., Tatter D. The changing incidence of association of hepatitis B with hepatocellular carcinoma in California. Am J Clin Pathol. 1977 Jul;68(1):1–7. doi: 10.1093/ajcp/68.1.1. [DOI] [PubMed] [Google Scholar]
  9. Shikata T., Yamazaki S., Uzawa T. Hepatocellular carcinoma and chronic persistent hepatitis. Acta Pathol Jpn. 1977 May;27(3):297–304. doi: 10.1111/j.1440-1827.1977.tb00156.x. [DOI] [PubMed] [Google Scholar]
  10. Snyder F., Wood R. Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues. Cancer Res. 1969 Jan;29(1):251–257. [PubMed] [Google Scholar]
  11. Tong M. J., Sun S. C., Schaeffer B. T., Chang N. K., Lo K. J., Peters R. L. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med. 1971 Nov;75(5):687–691. doi: 10.7326/0003-4819-75-5-687. [DOI] [PubMed] [Google Scholar]
  12. Wu P. C., Lam K. C. Cytoplasmic hepatitis B surface antigen and the ground-glass appearance in hepatocellular carcinoma. Am J Clin Pathol. 1979 Feb;71(2):229–234. doi: 10.1093/ajcp/71.2.229. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES